Moderna has been coping without one of its vaccine-manufacturing facilities, which hasn't been cleared by the FDA to make the new booster shots.
Merck's inability to close the biggest pharmaceutical deal in two years shows just how hard it is to put a price tag on a promising...
Moderna claims Pfizer and BioNTech infringed on its patents. This sets the stage for a massive legal clash between the three vaccine titans.
Crispr gene-editing pioneer Jennifer Doudna talks about the advances in the last decade.
Amazon hired an executive from Providence health system to work on it's partnerships with medical providers.
Private investors, retailers and health insurers are pumping billions of dollars into primary care — one of American medicine's least lucrative practices.